F. Borrosch

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo

Thomas Dirschka, Peter Radny, R. Dominicus et al. · British Journal of Dermatology · 2011 · 181 citations

Medicine, Dermatology, Pharmacology +15

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study

Rolf‐Markus Szeimies, Peter Radny, Michael Sebastian et al. · British Journal of Dermatology · 2010 · 125 citations

Medicine, Dermatology, Ophthalmology +8

Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies

Axel Hauschild, Eggert Stockfleth, Georg Popp et al. · British Journal of Dermatology · 2009 · 120 citations

Medicine, Dermatology, Surgery +11

Long‐term (6 and 12 months) follow‐up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF‐200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis

Thomas Dirschka, Peter Radny, R. Dominicus et al. · British Journal of Dermatology · 2012 · 102 citations · Full text

Medicine, Dermatology, Ophthalmology +14

Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data

Rolf‐Markus Szeimies, Eggert Stockfleth, Georg Popp et al. · British Journal of Dermatology · 2009 · 75 citations

Medicine, Dermatology, Surgery +13